Day: November 5, 2024

Cantargia Presents Promising Preclinical Results on Nadunolimab With Antibody-Drug Conjugates at Major Immuno-Oncology Conference

LUND, SWEDEN / ACCESSWIRE / November 05, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported preclinical results...

error: Content is protected !!